CLINICAL_TRIALS
trial_result
· 2013-08-23
Clinical Trial Update: Azithromycin Combination Therapy for the Treatment of Severe Malaria [Phase 2]
Summary
Phase 2 trial evaluating azithromycin in combination therapy for severe Plasmodium falciparum malaria has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of Vienna | Conditions: Falciparum Malaria | Phase 2 | Status: COMPLETED